Bright's disease today: the pathogenesis and treatment of glomerulonephritis--I

今日布莱特氏病:肾小球肾炎的发病机制和治疗——第一部分

阅读:1

Abstract

Since Bright's day the study of glomerulonephritis has largely consisted in the observation of the clinical, biochemical, and morphological characteristics of patients. Linked to this has been the attempt to name and classify these data in a fashion which improved prediction of outcome and response to treatment. This has proved difficult, since there is no absolute correspondence between clinical syndromes and the morphological findings in the kidney. The histological data have, however, allowed good prediction of prognosis and response.We now have enough information from experimental models of nephritis and from clinical observation to outline the pathogenesis of glomerulonephritis. Immune mechanisms are certainly concerned in some patients, the role of chronic soluble complex deposition in the kidney being particulary important. Non-immunological origins and mediation of injury, however, are at least as important. Injury to the glomerulus is mediated through the interaction of complement and coagulation mechanisms, leading through the release of soluble factors to inflammation. Repair is probably central in producing irreversible glomerular damage.Treatment can now be directed towards the events concerned in the pathogenesis of nephritis, the most accessible at the moment being the immediate mediators of injury. At a more fundamental level better identification in individual patients of the events leading to the injury is needed, such as the isolation, avoidance, or elimination of the antigens involved in chronic soluble complex disease. Laboratory techniques to begin these investigations in man are now available and need to be applied more widely in the clinical field to patients with glomerulonephritis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。